chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Left side lymph nodes under armpit swollen one day after vaccination; Dose number: 3; This is a spontaneous report from a contactable reporter (consumer or other non HCP). The reporter is the patient (Pfizer colleague).  A 44-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 02Dec2021 at 11:00 (Lot number: unknown) at the age of 44 years as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "Iodine contrast media allergy" , notes: Known allergy: iodine contrast dye. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot number: EL3247, Route of administration: Unspecified), administration date: 01Mar2021, when the patient was 43 years old, for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE, Lot number: EL3247, Route of administration: Unspecified), administration date: 22Mar2021, when the patient was 43 years old, for COVID-19 immunisation.  The following information was reported: IMMUNISATION (non-serious) with onset 02Dec2021 at 11:00, outcome "unknown", described as "Dose number: 3"; LYMPHADENOPATHY (non-serious) with onset 03Dec2021 at 21:00, outcome "not recovered", described as "Left side lymph nodes under armpit swollen one day after vaccination". Therapeutic measures were not taken as a result of lymphadenopathy.  Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Within 24 hours post vax, pt developed an injection site reaction characterized by swelling the size of a quarter, pain and redness. The also developed fever of 103 and a severe headache. On 11/23/99, the pt developed chills and malaise; he was seen by the physician. The pt's heart rate was 100. He was dyspneic and had a cough. His oxygen saturation was 93% at rest and 91% with exercise. He was hospitalized due to ARDS and transferred to ICU within 2 to 3 days.
Diffuse hypersensitivity reaction, rash (pruritic, diffuse erythematous, slightly raised blotchy rash with small vesicles. Some excoriation from itching. Rash present on stomach, forearms, hands, feet, armpits).
Pt's arm was swollen, red, hot to touch w/mild pain - mostly a few inches below injection site around elbow area.
24 hours after this vaccine Pt developed a red arm. It was puffy and hot to the touch. It went from his neck to his wrist, the entire arm that received the vaccine was red. After 3 days it went away and we thought it was going to be ok because he had never had a reaction before. Approximately 45 days later Pt began feeling unwell. He went to his nephrologist who ran routine blood tests and was shocked to see that Pt was now extremely anemic. His hemoglobin was 8.8. Pt had routine blood work done in December 2021 and his hemoglobin was 12.5. From December 2021 to March 2022 Pt became severely anemic, and this required hospitalization to try and correct the low iron. Nothing has changed from December when Pt was normal except that he got the COVID shot. The vaccine made him anemic and he now requires IV infusions of iron.
Vaccine underdose; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (Vaccine underdose) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (Vaccine underdose) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (Vaccine underdose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (Vaccine underdose).    No concomitant medications were reported. It was unknown whether patient received any other vaccines in the 4 weeks prior to COVID-19.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Live Significant Follow-up appended: Patient details (Age group) was added.
Patient inadvertently received vaccine after published expiration date. Moderna Company analyzed lot 007B21A and advised vaccine maintained activity necessary to protect against covid 19 at time of administration. Also patient did not call in with adverse event.  This is administrative error without adverse event.
Information has been received from a healthcare professional concerning a patient who on 15-AUG-2008 was vaccinated with a second dose of ROTATEQ vaccine live (human-bovine) that was greater than 10 weeks from the previous dose. The first dose of ROTATEQ vaccine live (human-bovine) was administered on 03-JUN-2008. There were no problems reported. At the time of the report, the patient's status was unknown. There was no product quality complaint involved. Additional information has been requested.
Starting Friday, June 4th I had Chronic fatigue, muscle weakness, headache, sweats, and chills for 4 days. I couldn't eat or drink anything. All I did was sleep and get up to go pee. I really felt like I was dying.
Patient received her vaccine around 12:30 pm and reported no adverse events at that time. When her shift at work ended she went home. After she arrived at home, she ate some food because she said she had not eaten anything all day. Shortly after eating (around 1:50 pm), she reportedly fainted. The patient said she came to on her floor and assumed she must have fainted. She said she doesn't believe she hit her head, but may have landed on her shoulder because that hurt a little bit.
Received Pneumovax on 9/15/00 and on 9/16/00, temperature was 102F and went up to 106F. Child was seen in ER on 9/17/00 PM. Had ? "otitis/pharyngitis" but none found. On 9/18/00 had vomiting and diarrhea. Off medicines on 9/17/00. Still febrile, last night, 9/17/00.
Patient complained of shortness of breath shortly after receiving the vaccine. After 15 minutes patient complained increased shortness of breath and requested transportation to Hospital ER. Patient left the facility with consistent V/s's but feeling much worst per Dr.'s note. Patient sent to ER by ambulance stationed on site. EMS at this facility assisted the MD and transported the patient to the ER.
Insect Bite Type Reaction; red; itchy; Swollen; This spontaneous case was reported by a physician and describes the occurrence of ARTHROPOD BITE (Insect Bite Type Reaction), ERYTHEMA (red), PRURITUS (itchy) and SWELLING (Swollen) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     Concomitant products included PREDNISONE for an unknown indication.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHROPOD BITE (Insect Bite Type Reaction), ERYTHEMA (red), PRURITUS (itchy) and SWELLING (Swollen). At the time of the report, ARTHROPOD BITE (Insect Bite Type Reaction), ERYTHEMA (red), PRURITUS (itchy) and SWELLING (Swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   patient used unspecified vitamins as concomitant medications.
Left arm pain at injection site for a few days after the vaccine, plus headache and some fatigue. This was typical of my reaction after first two doses. Symptoms seems to resolve after a few days.    After about a week, I noticed left arm pain in the area of the vaccination. This pain progressed over the next week from noticeable to severe the area of the injection site, area of my upper left arm to shoulder, and in left trapezius muscle.  No numbness, weakness, tingling, or loss of strength in my left hand.  Severe left arm, left shoulder pain/pain in left trapezius muscle was not resolved with Aleve at the maximum daily dose.  As pain progressed, it interfered with daily activities and sleep.  After two weeks the pain had not resolved and I went to urgent care.  The urgent care doctor prescribed steroids for inflammation and muscle relaxers for the pain.  I started taking the medication February 4, 2022.  I intend to see my primary care doctor (listed as the primary POC for this issue) after the five day course of prednisone in the pain has not resolved.
The patient was given Tdap by MA on 4/13/2022. The patients' mother was made aware of the error and the patient remained in the office for observation for 30 to 45 minutes to make sure no immediate adverse reactions presented.
Generalized Hives on trunk and limbs, neck and face.  Benadryl 75 mg oral, reducing hives by 80%
pt states redness from injection site down to elbow with pain & itchy feeling early next day (Sunday). Pt doesn't seem too concerned she iced it and it felt better. Will be taking tylenol as well.
This spontaneous report received from a nurse referred to an unknown number of patients of unknown age and gender. The patients' medical histories, concomitant medications and drug histories are all unknown. On an unknown dates in 2016, an unknown number of patients received GARDASIL 9 (lot: M023169, expiry: 13-JUN-2018) after a temperature excursion that occurred on 21-NOV-2016. The reporting nurse stated that none of the patients involved had reported adverse events or symptoms after receiving their vaccination. The patients' laboratory data was unknown. This is one of the three reports received from the same reporter. Additional information has been requested.
patient had first vaccination 1/30/21. He reported rash that developed on his left anterior forearm, about 8 days later, red itchy about 8 cm. This is the same arm he had the vaccination in. This gradually improved but did not resolve prior to time of second vaccination 2/27/21. Subsequent to this rash increased and persisted. No treatment but patient sent photographs via secure email. He was seen for follow-up on 4/15/21 and still had very mild erythema but no itching to the area.
20 minutes post vax, the pt developed swollen eyes, red splotchy rash all over, runny nose. EMS was called and the child was given Benadryl. Red area at site of vax remained for 2 days.
After 7 minutes, post vax, parents noticed injection site edema and erythema. Notified doctor of reaction as left arm continued to swell. Order given for Visteril IM to right thigh given at 09:17. Pt crying in daddy's arms. Order given for epinephrine given to left upper arm. Severe edema and erythema was noted at site. Lung sounds, bilaterally clear. Pt kept in office 40 minutes. Rechecked by physician; sleeping in mother's arms. Edema resolving. Seen in office on 5/10/00 at 11:15; left thigh at site of DTAP noted to have moderate edema and erythema. Site was warm to touch and tender. Pt will walk on leg without difficulty but prefers not to. Doctor notified of reaction and examined pt and area noted to be 3 1/2" wide by 2" tall.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. There was no information regarding the patient's pertinent medical history, drug reactions, allergies or concomitant therapies provided. On 13-FEB-2017, the patient was vaccinated with incorrectly stored dose of M-M-R II (dose, frequency, route of administration were not reported, lot # L049314, expiration date 03-DEC-2017, status albumin: recombinant human albumin (rHA)). No adverse effects were reported. Administered dose of vaccine experienced the temperature excursion of -14.4 degrees Celsius for 54 minutes. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information is not expected, all information has already been obtained.; Sender's Comments:  US-009507513-1611USA011831: US-009507513-1611USA004113: US-009507513-1705USA009742:
pt admitted to facility for skilled nursing care and strengthening after recent hospitalization for ARF due to COVID pneumonia and acute CHF; DNR; congested with non-productive cough, increased weakness; pt was found in bed deceased; per death certificate, cause of death is COVID pneumonia, CHF, IDDM
Breakthrough Covid case; cough, chills, body aches 2 days after exposure.
Patient have 7 raised red spots at administration site that were itchy. They appeared 2 days after vaccine was given.
Right arm swollen at injection site. Swelling size of silver dollar. Area warm to the touch. Patient complaining of pain with movement.
After vaccination, patient waited in the lobby with dad and brother for about 5 minutes. When they got on the elevator, patient states she started to feel dizzy and fainted, hitting her head on the way down. Dad quickly hit the button to open the elevator since it had not started to go down yet. They came to one of the clinic rooms and patient was told to lay down. Patients BP was 87/51, Pulse 70, R 18, Temp 98.7, and was pale. We gave her a granola bar and water. After about 5 minutes, patient stated feeling better and color started returning to face. Denies nausea or any additional symptoms. At 3:15pm her BP was 108/77. At 3:25pm, her BP was 113/64. Patient remained feeling  well after sitting up on the cot. Explained to dad it is his choice to go to FMD or ER to have treatment from fall. Discussed symptoms to be aware of in regards to head injury. Dad states understanding. Denies additional questions/concerns. Patient ambulates to car with no issues.
So the 2nd dose, it started within 5 -6 hours - for 24 hours after vaccine - I could barely move. I felt like I had a lead weight in. My daughter in law had to help me get to the restroom. I could not eat or drink. I couldn't focus on anything. I was completely out of it for at least 24 hours - and still ongoing with fatigue; problems with mobility and joint stiffness, pain and tenderness. Extreme thirst - I drank three or four liters of seltzer or water before I got sick and during that night. It is still going on -the joint stiffness - especially in the morning and tenderness over long bones. Mobility is very limited and different then it had been before.  And I feel extremely fatigued. I developed kind of arthritis - I have been referred to Rheumatologist - which I've never had before. I am theoretically disabled right now. I'm sure it's from vaccine.
difficulty breathing, shortness of breath; weakness; Coughing; felling tired; Nose dripping like she is going to get sick; headache; arm pain three hours after the injection; difficulties moving of right arm; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), VACCINATION SITE PAIN (arm pain three hours after the injection), VACCINATION SITE MOVEMENT IMPAIRMENT (difficulties moving of right arm), DYSPNOEA (difficulty breathing, shortness of breath) and ASTHENIA (weakness) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.     On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, the patient experienced HEADACHE (headache), VACCINATION SITE PAIN (arm pain three hours after the injection) and VACCINATION SITE MOVEMENT IMPAIRMENT (difficulties moving of right arm). On 19-Apr-2021, the patient experienced DYSPNOEA (difficulty breathing, shortness of breath), ASTHENIA (weakness), COUGH (Coughing), FATIGUE (felling tired) and RHINORRHOEA (Nose dripping like she is going to get sick). The patient was treated with ACETAMINOPHEN (oral) at a dose of 500 milligram twice a day. At the time of the report, HEADACHE (headache), VACCINATION SITE PAIN (arm pain three hours after the injection), VACCINATION SITE MOVEMENT IMPAIRMENT (difficulties moving of right arm), DYSPNOEA (difficulty breathing, shortness of breath), ASTHENIA (weakness), COUGH (Coughing), FATIGUE (felling tired) and RHINORRHOEA (Nose dripping like she is going to get sick) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications include iron supplements and multivitamins .
This Non valid spontaneous report was received from a registered nurse and refers to an unspecified number of unspecified patients of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On dates on or after 21-SEP-2017, the patients were vaccinated with improperly stored dose of PEDVAXHIB for prophylaxis, lot# N000238 with expiration date of 25-OCT-2019, lot# N003701 with expiration date of 01-NOV-2019, lot# N008079 with expiration date of 02-DEC-2019, lot# N012920 with expiration date of 07-FEB-2020 (strength, dose, route and frequency were not reported); or with improperly stored dose of RECOMBIVAX HB for prophylaxis, lot# N020613 with expiration date of 05-MAY-2020, lot# N002202 with expiration date of 04-NOV-2019, lot# N011851 with expiration date of 19-DEC-2019; or with improperly stored dose of ROTATEQ orally, for prophylaxis, lot# N000175 with expiration date of 20-SEP-2018, lot# N005618 with expiration date of 04-OCT-2018, lot# N005078 with expiration date of 22-NOV-2018; or with improperly stored dose of VAQTA for prophylaxis, reported lot# M019924 with expiration date of 02-SEP-2018, lot# N008823 with expiration date of 26-MAY-2018. No adverse effects were reported. It was stated that the vaccines underwent a temperature excursion of 32°F (degrees Fahrenheit) to 35°F for 40 minutes; No previous temperature excursion was done. The call was because of a "data logger". This is a non-valid case due to lack of patient identifier. Follow up information was received from the registered nurse 30-APR-2018. The nurse stated the temperature excursion was stable and they had two refrigerators that held the related vaccines. The nurse was not able to provide patients' names or initials, or ages, but was able to provide number of patients, gender information, and vaccination dates. This report referred to three female patients vaccinated with improperly stored VAQTA (lot# N019924 with expiration date 02-SEP-2018) on 25-SEP-2017. Upon receipt of follow-up information it was determined that this case is now valid because patient identifier was received. This is one of several reports received form the same reporter (link reports: 1710USA004069, 1805USA001661, 1805USA004617, 1805USA004618, 1805USA004590, 1805USA004591, 1805USA004592, 1805USA004593, 1805USA004674, 1805USA004675, 1805USA004676, 1805USA004677, 1805USA004678, 1805USA004679, 1805USA004680, 1805USA004681, 1805USA004682, 1805USA004683, 1805USA004967, 1805USA004968, 1805USA004969, 1805USA004970, 1805USA004972, 1805USA004973, 1805USA004974, 1805USA004975, 1805USA004976, 1805USA004977, 1805USA004978, 1805USA004979, 1805USA004980, 1805USA004981, 1805USA004982).
7/29/05 Developed rash on left leg and buttocks. 8/10/05 Seen by Pediatrician. Dx: Shingles
No adverse event. Administration error. Accidentally given 2nd flu booster (3rd dose in season) in pediatric patient
She is worried about the red dots. She is seriously frightened. She is scared of all that; She is worried about the red dots. She is seriously frightened. She is scared of all that; This is a spontaneous report from a contactable consumer from a Pfizer-sponsored program. This consumer reported for a female patient (reporter's wife). A female patient of an unspecified age received second dose of bnt162b2 (BNT162B2, Batch/Lot number was not reported), via an unspecified route of administration on 20May2021 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced she is worried about the red dots. she is seriously frightened. she is scared of all that. Reporter stated, "I am here to report a side effect. My wife's name is (Not clarified further) it is about her (Not clarified further). She has got two small dots on it. I am reporting a side effect. She has got the Pfizer shot, the second one on Thursday last week. She got the second shot last week on Thursday. She noticed two small dots the size of diamond on her foot. She is worried about the red dots. She is seriously frightened. She is scared of all that. She has got two dots one down by the pinkie toe one of them is the size of a diamond one up at the regular foot, the size of a diamond. It is faint, it is very faint. But they are red dots." When probed for permission to probe, Reporter stated, "She just wants to know she should worry about it or not?". The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pfizer dose 1 - left arm hurt for 3 days - used ice pack and Advil to ease Pfizer dose 2 - started bleeding upon receiving the vaccine. Left arm again hurt the evening of the shot.  Next morning I was in a lot of pain and my arm had a red ring and lump. Very tender.  I also had a mild headache which turned into a migraine in the evening.   Third day after vaccine my arm still hurts and the red ring has grown in size and mildly itches.  (As I type I am in day 3).
I am a registered nurse. I also am very sensitive to joint pain and muscle pain due to my lupus so I was not surprised by my ?overreaction to the soreness of both injections. However: although I was one of the people who had a severe reaction to the injection in terms of the arm pain, I also experienced a lot of nerve pain down the arm injected into my hand and fingers from the swelling. I also had a large lump with redness and heat. It was more severe with dose number two. I also had pain into my left shoulder and neck. This didn?t concern me and I expected it. I also had severe joint pain bilaterally in all of my joints with malaise and fatigue. This also didn?t concern me. However in February after my second  Moderna vaccine, I began to experience shooting pain in my left back and chest ? just under my left shoulder blade and sometimes running around into my sternum area ?only when lying in the supine position (flat on my back) and only beginning a few minutes after lying down upon taking in a deep breath.  This pain was relieved by sitting up. Initially I thought I had a rib out of place and went to a chiropractor to have an adjustment. After a few visits to the chiropractor and some  Ice / massage, I still have this pain, now on both sides with shortness of breath. I feel it is connected to the vaccine.
No s/y occurred, the MMR was given IM instead of sub-q in (R) deltoid.
all symptoms began approx. 12 hours post vaccination Duration 2 hours: Full body tremors, sweating, moderate nausea  Duration 36 hours: severe headache, moderate-severe joint and generalized muscle pain, severe fatigue 600mg ibuprofen taken at 20 hours post vaccination (8 hours after symptoms began). 400mg ibuprofen taken every 4 hours after for the next 30 hours.